Human potential : Early trials suggest it may improve immune health in older adults and treat age-related conditions like gum disease
To reduce side effects Nausea, vomiting, constipation and fatigue are among the most common side effects of GLP-1 drugs, and how hard they hit can depend, at least in part, on the dose
In a post-hoc analysis of microalbuminuria during follow-up, GLP1-RA users has significantly lower levels compared with DPP4i users
I 2 = 0%), urinary tract infection (OR: 2.31, 95% CI: 1.00, 5.34
Nng o c ti phi l 6-8mmol/l
Conclusion: Synthesizing a Strategic Defense for GLP-1 Assets Maximizing market exclusivity for GLP-1 receptor agonists is no longer a linear process of patent defense but a multidimensional orchestration of law, science, and economics